Rimjhim Agarwal | 2024 SPARK Finalist | Philanthropy SPARKS Breakthroughs

  Рет қаралды 295

La Jolla Institute for Immunology

La Jolla Institute for Immunology

Күн бұрын

Hear from 2024 SPARK finalist, Rimjhim Agarwal about the project she is proposing for a 2024 SPARK Tullie and Rickey Families SPARK Award, and the impact this funding could have on her research and career. Her SPARK project seeks to answer the question, “Does chronic chikungunya infection resemble an autoimmune disease?” More information about this project and The Tullie and Rickey Families SPARK Awards for Innovations for Immunology is available at: donate.lji.org...
About the SPARK program: The Tullie and Rickey Families SPARK Awards for Innovations in Immunology provides flexible start-up funding that enables LJI’s early career investigators to act on their promising projects for bold new approaches to diagnoses, treatments, and possibly even cures for diseases that afflict us today. It fills the gap between scientists’ imagination and that first solid set of data that allows them to attract additional funding to further their research and ultimately make life-saving discoveries. Each year, LJI receives dozens of proposals from its graduate students and postdoctoral scientists. A panel that includes Institute scientists, board members, and top business leaders reviews the proposals, selects the finalists, and has each of them present their projects in person. The finalists are then ranked in order to receive funding based on the total amount raised for the SPARK program each year from donor contributions. Each SPARK award provides $25,000 in funding that must be spent within eight months.
Support The Tullie and Rickey Families SPARK Awards for Innovations in Immunology: donate.lji.org...
__________________________________________
Sign-up to receive our newsletter and/or our free science magazine: www.lji.org/si...
Follow along on Facebook: / lifewithoutdisease
Instagram: / lajollainstitute
Twitter: / ljiresearch
LinkedIn: / la-jolla-institute

Пікірлер: 1
@architaggarwal2864
@architaggarwal2864 8 ай бұрын
Chikungunya doesnt stand a chance against Rimjhim!! 🏆
Unraveling the Future: Predicting the Influenza Vaccine Response through Machine Learning
35:51
How Biosafety Level 3 laboratories keep researchers safe and what you need to know to work in one.
22:08
Новый уровень твоей сосиски
00:33
Кушать Хочу
Рет қаралды 5 МЛН
GIANT Gummy Worm Pt.6 #shorts
00:46
Mr DegrEE
Рет қаралды 102 МЛН
BlackRock: The Conspiracies You Don’t Know
15:13
More Perfect Union
Рет қаралды 2,3 МЛН
ADD/ADHD | What Is Attention Deficit Hyperactivity Disorder?
28:15
Understood
Рет қаралды 9 МЛН
A *REALISTIC* Day in the Life of a Harvard Computer Science Student
5:44
Harvard College Admissions & Financial Aid
Рет қаралды 58 М.
Studying T cell immunology in engineered animal models - Nikhil Joshi, Phd
53:54
La Jolla Institute for Immunology
Рет қаралды 391
3MT: the three most common mistakes
7:34
ANU TV
Рет қаралды 126 М.
What is a Flow Cytometry Core?
7:40
La Jolla Institute for Immunology
Рет қаралды 322
Potential role of monocytes in lupus nephritis - Anne Davidson, MBBS
36:42
La Jolla Institute for Immunology
Рет қаралды 173
Новый уровень твоей сосиски
00:33
Кушать Хочу
Рет қаралды 5 МЛН